Cigna Group Form 4 insider transactions
NYSE
Director Granger Elder exercised stock options and sold Cigna shares under a pre-arranged 10b5-1 trading plan.
NYSE
Director George Kurian reports changes in beneficial ownership of Cigna Group stock, including the acquisition of phantom stock units through a deferred compensation plan.
NYSE
Director Eric C. Wiseman reports acquiring phantom stock units in Cigna Group through a deferred compensation plan.
NYSE
Noelle K. Eder, EVP and Global Chief Information Officer of Cigna Group, reports the acquisition and disposal of company stock and stock options under a pre-arranged trading plan and 401(k) participation.
NYSE
Mary T. Agoglia Hoeltzel, SVP Tax & Chief Accounting Officer of Cigna Group, exercised stock options and sold shares on May 14, 2024.
NYSE
Director Philip Ozuah reports acquiring 539 shares of Cigna Group common stock on April 24, 2024.
NYSE
Director Eric C. Wiseman acquired 539 shares of Cigna Group common stock on April 24, 2024.
NYSE
Director Mark McClellan reported acquiring 539 shares of Cigna Group common stock on April 24, 2024.
NYSE
Director George Kurian acquired 539 shares of Cigna Group common stock on April 24, 2024.
NYSE
Director Donna F. Zarcone reported acquiring 539 shares of Cigna Group common stock on April 24, 2024.
NYSE
Director Kimberly A. Ross reports acquiring 539 shares of Cigna Group common stock on April 24, 2024.
NYSE
Kathleen Mazzarella, a director at Cigna Group, reported acquiring 539 shares of common stock on April 24, 2024.
NYSE
Director Neesha Hathi filed a Form 4 disclosing changes in her beneficial ownership of Cigna Group stock.
NYSE
Director Elder Granger reported acquiring 539 shares of Cigna Group common stock on April 24, 2024.
NYSE
Director Eric Foss reports acquiring 539 shares of Cigna Group common stock on April 24, 2024, bringing his total holdings to 35,276 shares.
NYSE
Director William J DeLaney III acquired 539 shares of Cigna Group common stock on April 24, 2024.
NYSE
Form 4: Cigna Group CEO David Cordani Executes Stock Option and Reports Changes in Beneficial Ownership
Cigna Group's Chairman and CEO, David Cordani, exercised stock options and reported changes in his beneficial ownership of company stock, including transactions made under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Cigna Group's Chairman and CEO, David Cordani, exercised employee stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Cigna Group's CEO, David Cordani, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Cigna Group's CEO, David Cordani, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Eric Palmer, a Cigna executive, reports changes in his beneficial ownership of Cigna Group stock due to the settlement of strategic performance shares and tax obligations.
NYSE
Noelle K. Eder, EVP and Global Chief Information Officer of Cigna Group, reports acquisition and disposal of common stock shares related to performance share settlements, tax obligations, and 401(k) participation.
NYSE
Nicole Jones, a Cigna executive, reported the acquisition and disposal of company stock, including shares received from performance awards and shares sold to cover tax obligations.
NYSE
David Cordani, Chairman and CEO of Cigna Group, reports acquisition and disposal of company stock, including shares received from performance-based compensation and shares sold to cover tax obligations.
NYSE
David Brailer, EVP & Chief Health Officer at Cigna Group, reports acquisition and disposal of Cigna common stock on March 1, 2024, according to a Form 4 filing with the SEC.
NYSE
Brian Evanko, EVP, Chief Financial Officer and President & CEO, Cigna Healthcare, reports changes in beneficial ownership of Cigna Group stock due to vesting of performance shares, tax withholdings, and 401(k) participation.
NYSE
Michael Triplett, a Special Advisor at Cigna Group, reported the acquisition and disposal of company stock, including shares received from performance-based compensation and shares sold to cover tax obligations.
NYSE
Mary Agoglia Hoeltzel, SVP Tax & Chief Accounting Officer of Cigna Group, reports acquisition and disposal of common stock due to settlement of strategic performance shares and tax obligations.
NYSE
Cigna Group officer Michael Triplett reports the acquisition of common stock and employee stock options, along with adjustments to existing holdings, as per a Form 4 filing with the SEC.
NYSE
Eric Palmer, an executive at Cigna Group, reported the acquisition of shares and stock options, according to a Form 4 filing with the SEC.